Add Yahoo as a preferred source to see more of our stories on Google. Saget first supported the non-profit in 1991, and then became an outspoken advocate after his sister Gay was diagnosed with the ...

Add Yahoo as a preferred source to see more of our stories on Google. She was 44 in 1992 when she was diagnosed with systemic scleroderma, a disease that strikes mostly women in the prime of their ...

GERMANTOWN, Md.--(BUSINESS WIRE)--Theraly Fibrosis, a preclinical-stage biotechnology company focused on development and commercialization of drugs for various fibrotic diseases today announced that ...

AMSTERDAM — For patients with diffuse cutaneous systemic sclerosis, an autoimmune disease for which there are few treatment options, lenabasum (JBT-101, Corbus Pharmaceuticals) shows potential, new ...

ATLANTA - New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, found no clear association between immunosuppressive or anti-fibrotic ...

As people learned about the death of comedian Bob Saget, many close to him suggested that a donation to research into a medical condition his sister suffered with and died from would be a fitting ...

As Bob Saget is remembered by his friends and co-stars, one memory that stands out is his commitment to finding a cure for scleroderma, a rare disease for which Saget was the most high-profile ...

U.S. Comedian Bob Saget has died at the age of 65. He was known for playing the character of Danny Tanner in the television series Full House. Saget was found dead in a hotel room in Florida on ...

The drug tofacitinib was well tolerated among patients with early scleroderma, primarily affecting the protein interferon both in fibroblasts and keratinocytes. Researchers say the drug is safe and ...

MONTREAL, January 27, 2026--(BUSINESS WIRE)--Indero is pleased to announce a strategic collaboration with the World Scleroderma Foundation (WSF) to support WSF SHIELD platform trial, a randomized, ...

SAN DIEGO--(BUSINESS WIRE)--Paracrine, Inc., announced today the online publication (ahead of print) of the findings from the STAR I trial in Arthritis & Rheumatology Journal, the official journal of ...